Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03711266 · ClinicalTrials.gov registry record · NA

Implementing PTSD Treatment in FQHCs for Michigan Medicaid Enrollees

A NA study of PTSD, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
35
Enrollment target
2
Study locations

NCT03711266 is a NA study of PTSD that has completed, run by University of Michigan. The registered enrollment target is 35 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03711266, a NA study of PTSD, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this project is to expand access to trauma-focused treatment among Medicaid Enrollees with PTSD, thereby improving the quality of mental health services delivered to this population. Specifically, the project goals are to evaluate the delivery and sustainability of a brief trauma-focused treatment, Prolonged Exposure for Primary Care (PE-PC), an evidence-based intervention for PTSD, when delivered via telehealth to patients enrolled at CHCs in Michigan.

Conditions Studied

Interventions

  • BEHAVIORAL PE-PC

Study Locations (2)

Michigan

  • Baldwin Family Health Care-Cadillac Clinic - Cadillac
  • Hamilton Community Health Network-Flint Clinic - Flint

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2018-11-01
Est. Completion 2020-09-30
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03711266

The ClinicalTrials.gov registry entry for NCT03711266 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (88% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which PE-PC is the first listed.

NCT03711266 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03711266 about?

NCT03711266 is a clinical study titled "Implementing PTSD Treatment in FQHCs for Michigan Medicaid Enrollees". The purpose of this project is to expand access to trauma-focused treatment among Medicaid Enrollees with PTSD, thereby improving the quality of mental health services delivered to this population. Specifically, the project goals are to evaluate the delivery and sustainability of a brief trauma-focu...

What is the current status of trial NCT03711266?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-11-01. Estimated completion is 2020-09-30.

What conditions does trial NCT03711266 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT03711266?

The interventions under investigation include: PE-PC (BEHAVIORAL).

Who is sponsoring clinical trial NCT03711266?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03711266 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.